Real-time enrollment status for this cutaneous lupus erythematosus clinical trial
Current Status
Terminated
Checked: March 2, 2026 at 12:06 PM UTC
| NCT Number | NCT05629208 |
| Recruiting Status | Terminated |
| Condition | Cutaneous Lupus Erythematosus |
| Phase | Clinical Trial |
| Target Enrollment | 33 participants |
| Active Locations | 21 sites in the US |
| Sponsor | Gilead Sciences |
| Last Updated on CT.gov | February 17, 2026 (1 week ago) |
As of March 2, 2026: Clinical trial NCT05629208 is currently terminated participants. This clinical trial study for cutaneous lupus erythematosus is not currently accepting new participants at 21 locations across the United States. The study is sponsored by Gilead Sciences. This status information is automatically verified from the official ClinicalTrials.gov registry.
No, NCT05629208 is currently terminated. The study may resume recruiting in the future.
This trial is recruiting at 21 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT05629208 was last updated 1 week ago (February 17, 2026). HelloStudys verifies this status automatically.